|
⚲
|
| Keyboard |
| Robert Falk | |
|---|---|
| Firm | |
| Address | Strawinskylaan 1577 Amsterdam, P7 1077 XX |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Bencis VII Cooperatief UA | 021-562401 | Executive Officer | of 698.8 M |
||
| Bencis VI CV | 021-369271 | Executive Officer | of 560.0 M |
||
| Arno Therapeutics Inc | 021-148137 | Director | 8.4 M of 13.2 M |
||
| 3DR Laboratories LLC | 021-108549 | Executive Officer | 0.2 M of 0.8 M |
||
| Apollo Capital Management LP | |||||
| Wolfcamp Co-Investors LP | 021-282801 | Executive Officer | 1.9 M | ||
| Apollo Special Situations Fund LP | 021-259485 | Executive Officer | 360.4 M of 750.0 M |
19.2 M | |
| Apollo ANRP Co-Investors II B LP | 021-246873 | Executive Officer | 23.4 M | 7.1 M | |
| Apollo Natural Resources Partners II LP | 021-246874 | Executive Officer | 3,151.7 M | 975.6 M | |
| Apollo Co-Investors VIII A LP | 021-207739 | Executive Officer | 210.2 M | 67.1 M | |
| Apollo Natural Resources Partners LP | 021-246874 | Executive Officer | 3,151.7 M | 27.7 M | |
| Related People Network |
|---|
| Network #3 at Apollo Capital Management LP — files alongside 27 co-filers |